BTEE - iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (IE00BDZVHG35)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选清除所有

保存关闭

(%)

IE00BDZVHG35

BTEE ISIN

交易所交易基金 (ETF)

基金类型

BlackRock

提供商

9,62 USD

每股资产净值 | 2026-07-10

2018-03-05

成立日期

2 每年的次数

股息的支付

CEOIES

CFI

BTEE

代码

Formed

Status

Equity

投资项目

Biotech

部门

USA

地区分布

Nasdaq Biotechnology Index(R)

基准

0.35 %

总成本比率

1.168,7 百万 USD

基金资产总量 | 2026-07-10

73,33 百万 USD

股票类资产 | 2026-07-10

是

UCITS

报价 (BTEE)

探索最全面的数据库

1 000 000

债券

80 234

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

债券筛选器
观察列表
Excel 附加组件

请求访问

价格动态的变化

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEE profile

The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 05.03.2018 with unique ISIN - IE00BDZVHG35. Main exchange is London S.E. (USD) and ticker symbol is BTEE. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) pays dividends 2 time(s) per year.

结构 BTEE 在 2026-07-09

下载结构至 Excel 文档

证券	值
VERTEX PHARMACEUTICALS INC	7,82%
AMGEN INC	7,61%
GILEAD SCIENCES INC	7,07%
REGENERON PHARMACEUTICALS INC	4,63%
ALNYLAM PHARMACEUTICALS INC	2,81%
REVOLUTION MEDICINES INC	2,73%
MODERNA INC	2,04%
BIOGEN INC	1,97%
ILLUMINA INC	1,97%
ROIVANT SCIENCES LTD	1,78%
ROYALTY PHARMA PLC CLASS A	1,73%
INSMED INC	1,72%
ARGENX SE ADR	1,69%
INCYTE CORP	1,59%
UNITED THERAPEUTICS CORP	1,58%
GUARDANT HEALTH INC	1,46%
VIATRIS INC	1,28%
NEUROCRINE BIOSCIENCES INC	1,22%
BRIDGEBIO PHARMA INC	1,19%
ASCENDIS PHARMA	1,14%
JAZZ PHARMACEUTICALS PLC	1,04%
MEDPACE HOLDINGS INC	1,03%
EXELIXIS INC	0,97%
MADRIGAL PHARMACEUTICALS INC	0,87%
AXSOME THERAPEUTICS INC	0,86%
SUMMIT THERAPEUTICS INC	0,81%
ARROWHEAD PHARMACEUTICALS INC	0,8%
CYTOKINETICS INC	0,79%
BIOMARIN PHARMACEUTICAL INC	0,78%
KRYSTAL BIOTECH INC	0,74%
BIONTECH SE ADR	0,73%
TEMPUS AI INC CLASS A	0,72%
IONIS PHARMACEUTICALS INC	0,72%
SANOFI ADR REPRESENTING SA	0,68%
BEONE MEDICINES AG	0,67%
KYMERA THERAPEUTICS INC	0,66%
HALOZYME THERAPEUTICS INC	0,63%
IMMUNITYBIO INC	0,62%
PRAXIS PRECISION MEDICINES INC	0,62%
NUVALENT INC CLASS A	0,61%
ALKERMES	0,6%
PROTAGONIST THERAPEUTICS INC	0,59%
CRINETICS PHARMACEUTICALS INC	0,59%
VAXCYTE INC	0,58%
SPYRE THERAPEUTICS INC	0,57%
IMMUNOVANT INC	0,57%
APOGEE THERAPEUTICS INC	0,56%
ABIVAX AMERICAN DEPOSITARY SHARES	0,55%
RHYTHM PHARMACEUTICALS INC	0,53%
MIRUM PHARMACEUTICALS INC	0,52%
PTC THERAPEUTICS INC	0,5%
COGENT BIOSCIENCES INC	0,47%
SCHOLAR ROCK HOLDING CORP	0,46%
XENON PHARMACEUTICALS INC	0,46%
CG ONCOLOGY INC	0,43%
LIGAND PHARMACEUTICALS INC	0,43%
ERASCA INC	0,4%
TWIST BIOSCIENCE CORP	0,39%
TRAVERE THERAPEUTICS INC	0,36%
CRISPR THERAPEUTICS AG	0,36%
AMNEAL PHARMACEUTICALS INC CLASS A	0,36%
ORUKA THERAPEUTICS INC	0,36%
DEFINIUM THERAPEUTICS INC	0,35%
EDGEWISE THERAPEUTICS INC	0,35%
CARIS LIFE SCIENCES INC	0,34%
10X GENOMICS INC CLASS A	0,34%
INDIVIOR PHARMACEUTICALS INC	0,34%
VERACYTE INC	0,32%
ACADIA PHARMACEUTICALS INC	0,3%
RELAY THERAPEUTICS INC	0,3%
TANGO THERAPEUTICS INC	0,3%
DENALI THERAPEUTICS INC	0,29%
STRUCTURE THERAPEUTICS ADR INC	0,29%
NEWAMSTERDAM PHARMA NV	0,28%
DYNE THERAPEUTICS INC	0,27%
ALUMIS INC	0,25%
BEAM THERAPEUTICS INC	0,25%
ARCUTIS BIOTHERAPEUTICS INC	0,24%
ADAPTIVE BIOTECHNOLOGIES CORP	0,24%
ULTRAGENYX PHARMACEUTICAL INC	0,23%
IDEAYA BIOSCIENCES INC	0,22%
GRAIL INC	0,22%
ENLIVEN THERAPEUTICS INC	0,21%
MBX BIOSCIENCES INC	0,21%
VERA THERAPEUTICS INC CLASS A	0,2%
KINIKSA PHARMACEUTICALS INTERNATIO	0,2%
DISC MEDICINE INC	0,2%
UNIQURE NV	0,19%
SUPERNUS PHARMACEUTICALS INC	0,19%
TARSUS PHARMACEUTICALS INC	0,18%
BIOCRYST PHARMACEUTICALS INC	0,18%
TREVI THERAPEUTICS INC	0,17%
NURIX THERAPEUTICS INC	0,17%
AGIOS PHARMACEUTICALS INC	0,17%
KODIAK SCIENCES INC	0,17%
PHARVARIS N V NV	0,17%
VERICEL CORP	0,17%
MINERALYS THERAPEUTICS INC	0,16%
OCULAR THERAPEUTIX INC	0,16%
LEGEND BIOTECH ADR REP CORP	0,15%

显示所有隐藏

Other - %

该基金其他股票

iShares Nasdaq US Biotechnology UCITS ETF

显示所有